vs
Esperion Therapeutics, Inc.（ESPR）与UNITIL CORP（UTL）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是UNITIL CORP的1.0倍（$168.4M vs $161.5M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 26.7%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs -4.9%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Unitil是一家跨州电力与天然气公用事业公司，业务覆盖美国新罕布什尔州、马萨诸塞州与缅因州。公司最早前身是1849年在缅因州成立的波特兰煤气灯公司，现企业主体于1984年设立，总部位于新罕布什尔州。目前公司总市值约6.8651亿美元，为约10.24万电力客户、超7.59万天然气客户提供服务。
ESPR vs UTL — 直观对比
营收规模更大
ESPR
是对方的1.0倍
$161.5M
营收增速更快
ESPR
高出117.1%
26.7%
两年增速更快
ESPR
近两年复合增速
-4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $161.5M |
| 净利润 | — | $19.0M |
| 毛利率 | — | — |
| 营业利润率 | 50.6% | 21.5% |
| 净利率 | — | 11.8% |
| 营收同比 | 143.7% | 26.7% |
| 净利润同比 | — | 21.8% |
| 每股收益（稀释后） | $0.32 | $1.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRUTL
| Q4 25 | $168.4M | $161.5M | ||
| Q3 25 | $87.3M | $101.1M | ||
| Q2 25 | $82.4M | $102.6M | ||
| Q1 25 | $65.0M | $170.8M | ||
| Q4 24 | $69.1M | $127.5M | ||
| Q3 24 | $51.6M | $92.9M | ||
| Q2 24 | $73.8M | $95.7M | ||
| Q1 24 | $137.7M | $178.7M |
净利润ESPRUTL
| Q4 25 | — | $19.0M | ||
| Q3 25 | $-31.3M | $-300.0K | ||
| Q2 25 | $-12.7M | $4.0M | ||
| Q1 25 | $-40.5M | $27.5M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $-29.5M | $0 | ||
| Q2 24 | $-61.9M | $4.3M | ||
| Q1 24 | $61.0M | $27.2M |
营业利润率ESPRUTL
| Q4 25 | 50.6% | 21.5% | ||
| Q3 25 | -11.4% | 6.9% | ||
| Q2 25 | 8.6% | 13.0% | ||
| Q1 25 | -34.0% | 27.0% | ||
| Q4 24 | -6.4% | 22.1% | ||
| Q3 24 | -31.0% | 6.2% | ||
| Q2 24 | 3.5% | 13.0% | ||
| Q1 24 | 52.5% | 24.7% |
净利率ESPRUTL
| Q4 25 | — | 11.8% | ||
| Q3 25 | -35.9% | -0.3% | ||
| Q2 25 | -15.4% | 3.9% | ||
| Q1 25 | -62.2% | 16.1% | ||
| Q4 24 | — | 12.2% | ||
| Q3 24 | -57.2% | — | ||
| Q2 24 | -83.9% | 4.5% | ||
| Q1 24 | 44.3% | 15.2% |
每股收益（稀释后）ESPRUTL
| Q4 25 | $0.32 | $1.05 | ||
| Q3 25 | $-0.16 | $-0.02 | ||
| Q2 25 | $-0.06 | $0.25 | ||
| Q1 25 | $-0.21 | $1.69 | ||
| Q4 24 | $-0.14 | $0.97 | ||
| Q3 24 | $-0.15 | $0.00 | ||
| Q2 24 | $-0.33 | $0.27 | ||
| Q1 24 | $0.34 | $1.69 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $15.6M |
| 总债务越低越好 | — | $670.5M |
| 股东权益账面价值 | $-302.0M | $609.6M |
| 总资产 | $465.9M | $2.1B |
| 负债/权益比越低杠杆越低 | — | 1.10× |
8季度趋势，按日历期对齐
现金及短期投资ESPRUTL
| Q4 25 | $167.9M | $15.6M | ||
| Q3 25 | $92.4M | $14.6M | ||
| Q2 25 | $86.1M | $8.5M | ||
| Q1 25 | $114.6M | $10.2M | ||
| Q4 24 | $144.8M | $6.3M | ||
| Q3 24 | $144.7M | $6.3M | ||
| Q2 24 | $189.3M | $2.8M | ||
| Q1 24 | $226.6M | $6.3M |
总债务ESPRUTL
| Q4 25 | — | $670.5M | ||
| Q3 25 | — | $670.5M | ||
| Q2 25 | — | $640.7M | ||
| Q1 25 | — | $642.1M | ||
| Q4 24 | — | $643.3M | ||
| Q3 24 | — | $643.3M | ||
| Q2 24 | — | $511.3M | ||
| Q1 24 | — | $512.8M |
股东权益ESPRUTL
| Q4 25 | $-302.0M | $609.6M | ||
| Q3 25 | $-451.4M | $597.2M | ||
| Q2 25 | $-433.5M | $532.8M | ||
| Q1 25 | $-426.2M | $534.1M | ||
| Q4 24 | $-388.7M | $512.5M | ||
| Q3 24 | $-370.2M | $502.4M | ||
| Q2 24 | $-344.2M | $508.8M | ||
| Q1 24 | $-294.3M | $510.8M |
总资产ESPRUTL
| Q4 25 | $465.9M | $2.1B | ||
| Q3 25 | $364.0M | $1.9B | ||
| Q2 25 | $347.1M | $1.9B | ||
| Q1 25 | $324.0M | $1.9B | ||
| Q4 24 | $343.8M | $1.8B | ||
| Q3 24 | $314.1M | $1.7B | ||
| Q2 24 | $352.3M | $1.7B | ||
| Q1 24 | $373.1M | $1.7B |
负债/权益比ESPRUTL
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 1.12× | ||
| Q2 25 | — | 1.20× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 1.26× | ||
| Q3 24 | — | 1.28× | ||
| Q2 24 | — | 1.00× | ||
| Q1 24 | — | 1.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $21.4M |
| 自由现金流经营现金流 - 资本支出 | — | $-36.3M |
| 自由现金流率自由现金流/营收 | — | -22.5% |
| 资本支出强度资本支出/营收 | 0.0% | 35.7% |
| 现金转化率经营现金流/净利润 | — | 1.13× |
| 过去12个月自由现金流最近4个季度 | — | $-53.8M |
8季度趋势，按日历期对齐
经营现金流ESPRUTL
| Q4 25 | $45.2M | $21.4M | ||
| Q3 25 | $-4.3M | $15.6M | ||
| Q2 25 | $-31.4M | $42.2M | ||
| Q1 25 | $-22.6M | $52.1M | ||
| Q4 24 | $-35.0M | $23.3M | ||
| Q3 24 | $-35.3M | $26.1M | ||
| Q2 24 | $-7.2M | $49.9M | ||
| Q1 24 | $53.8M | $26.6M |
自由现金流ESPRUTL
| Q4 25 | — | $-36.3M | ||
| Q3 25 | — | $-39.0M | ||
| Q2 25 | — | $2.0M | ||
| Q1 25 | — | $19.5M | ||
| Q4 24 | — | $-32.3M | ||
| Q3 24 | $-35.5M | $-31.3M | ||
| Q2 24 | $-7.3M | $13.2M | ||
| Q1 24 | $53.8M | $6.4M |
自由现金流率ESPRUTL
| Q4 25 | — | -22.5% | ||
| Q3 25 | — | -38.6% | ||
| Q2 25 | — | 1.9% | ||
| Q1 25 | — | 11.4% | ||
| Q4 24 | — | -25.3% | ||
| Q3 24 | -68.7% | -33.7% | ||
| Q2 24 | -9.9% | 13.8% | ||
| Q1 24 | 39.0% | 3.6% |
资本支出强度ESPRUTL
| Q4 25 | 0.0% | 35.7% | ||
| Q3 25 | 0.0% | 54.0% | ||
| Q2 25 | 0.0% | 39.2% | ||
| Q1 25 | 0.0% | 19.1% | ||
| Q4 24 | 0.0% | 43.6% | ||
| Q3 24 | 0.3% | 61.8% | ||
| Q2 24 | 0.1% | 38.3% | ||
| Q1 24 | 0.1% | 11.3% |
现金转化率ESPRUTL
| Q4 25 | — | 1.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 10.55× | ||
| Q1 25 | — | 1.89× | ||
| Q4 24 | — | 1.49× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 11.60× | ||
| Q1 24 | 0.88× | 0.98× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
UTL
暂无分部数据
